Table 3 Parameters from ROC analysis on serum Trx1 levels in patients with various cancers
Type of cancer | AUC* (±SEM) | Sensitivity (%) | Specificity (%) | Criterion (ng/ml) | # of serum (Grade) |
|---|---|---|---|---|---|
Breast/NFM | 0.911 ± 0.179 | 89.3 | 78.0 | >32.3390 | 197 (I/II/III) |
Colorectal/NFM | 0.687 ± 0.0425 | 68.3 | 61.0 | >29.0533 | 64 (I/II/III) |
Kidney/NFM | 0.633 ± 0.0617 | 46.7 | 81.0 | >32.9986 | 30 (I/II) |
Lung/NFM | 0.643 ± 0.0381 | 54.1 | 73.0 | >31.1820 | 108 (I/II/III/IV) |
Normal Control | - | - | - | - | 100 F/M: 50 F / 50 M |